76 related articles for article (PubMed ID: 31115569)
1. Paeoniflorigenone inhibits ovarian cancer metastasis through targeting the MUC1/Wnt/β‑catenin pathway.
Liu Q; Jiang L; Zhao Y; Su F; Li J; Tian X; Liu W; Jiang X; Xu Y; Tao F
Int J Mol Med; 2024 Jul; 54(1):. PubMed ID: 38785138
[TBL] [Abstract][Full Text] [Related]
2. The oncogenic role and regulatory mechanism of ACAA2 in human ovarian cancer.
Leng Y; Tian T; Tang B; Ma Y; Li Z; Shi Q; Liu J; Zhou Y; Wang W; Huang C; Zhao X; Feng W; Liu Y; Liang J; Liu T; Liu S; Ren Q; Liu J; Zhang T; Zhou J; Huang Q; Zhang Y; Yin B; Xu Y; Liu L; Shen L; Zhao H
Mol Carcinog; 2024 Jul; 63(7):1362-1377. PubMed ID: 38656551
[TBL] [Abstract][Full Text] [Related]
3. Systems biology approach to identify biomarkers and therapeutic targets for colorectal cancer.
Sadat Kalaki N; Ahmadzadeh M; Najafi M; Mobasheri M; Ajdarkosh H; Karbalaie Niya MH
Biochem Biophys Rep; 2024 Mar; 37():101633. PubMed ID: 38283191
[TBL] [Abstract][Full Text] [Related]
4. CD44v6, STn & O-GD2: promising tumor associated antigens paving the way for new targeted cancer therapies.
Lodewijk I; Dueñas M; Paramio JM; Rubio C
Front Immunol; 2023; 14():1272681. PubMed ID: 37854601
[TBL] [Abstract][Full Text] [Related]
5. Circulating microRNAs for Early Diagnosis of Ovarian Cancer: A Systematic Review and Meta-Analysis.
Frisk NLS; Sørensen AE; Pedersen OBV; Dalgaard LT
Biomolecules; 2023 May; 13(5):. PubMed ID: 37238740
[TBL] [Abstract][Full Text] [Related]
6. Rapid microRNA detection method based on DNA strand displacement for ovarian cancer cells.
Sun G; Chen C; Li X; Hong S; Gu C; Shi X
J Cancer; 2023; 14(5):707-716. PubMed ID: 37056384
[TBL] [Abstract][Full Text] [Related]
7. Negative regulation of CD44st by miR-138-5p affects the invasive ability of breast cancer cells and patient prognosis after breast cancer surgery.
Jian FX; Bao PX; Li WF; Cui YH; Hong HG
BMC Cancer; 2023 Mar; 23(1):269. PubMed ID: 36964570
[TBL] [Abstract][Full Text] [Related]
8. Circular Sponge against miR-21 Enhances the Antitumor Activity of Doxorubicin against Breast Cancer Cells.
Rama AR; Lara P; Mesas C; Quiñonero F; Vélez C; Melguizo C; Prados J
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499129
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic value of serum miR-21 in patients with ovarian cancer: a systematic review and meta-analysis.
Qiu L; Weng G
J Ovarian Res; 2022 May; 15(1):51. PubMed ID: 35501921
[TBL] [Abstract][Full Text] [Related]
10. The abnormal expression of chromosomal region maintenance 1 (CRM1)-survivin axis in ovarian cancer and its related mechanisms regulating proliferation and apoptosis of ovarian cancer cells.
Zhang J; Xu X; Chen Y; Guan X; Zhu H; Qi Y
Bioengineered; 2022 Jan; 13(1):624-633. PubMed ID: 34898375
[TBL] [Abstract][Full Text] [Related]
11. Progesterone Receptor Membrane Component (PGRMC)1 and PGRMC2 and Their Roles in Ovarian and Endometrial Cancer.
Peluso JJ; Pru JK
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885064
[TBL] [Abstract][Full Text] [Related]
12. CD44 as a tumor biomarker and therapeutic target.
Xu H; Niu M; Yuan X; Wu K; Liu A
Exp Hematol Oncol; 2020 Dec; 9(1):36. PubMed ID: 33303029
[TBL] [Abstract][Full Text] [Related]
13. Downstream Effectors of ILK in Cisplatin-Resistant Ovarian Cancer.
Reyes-González JM; Quiñones-Díaz BI; Santana Y; Báez-Vega PM; Soto D; Valiyeva F; Marcos-Martínez MJ; Fernández-de Thomas RJ; Vivas-Mejía PE
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32260415
[TBL] [Abstract][Full Text] [Related]
14. Wnt Signaling in Ovarian Cancer Stemness, EMT, and Therapy Resistance.
Teeuwssen M; Fodde R
J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31614568
[TBL] [Abstract][Full Text] [Related]
15. Promotion of ovarian cancer cell invasion, migration and colony formation by the miR‑21/Wnt/CD44v6 pathway.
Wang Y; Yang X; Yuan M; Xian S; Zhang L; Yang D; Cheng Y
Oncol Rep; 2019 Jul; 42(1):91-102. PubMed ID: 31115569
[TBL] [Abstract][Full Text] [Related]
16. MiR-27a promotes EMT in ovarian cancer through active Wnt/𝜷-catenin signalling by targeting FOXO1.
Zhang LY; Chen Y; Jia J; Zhu X; He Y; Wu LM
Cancer Biomark; 2019; 24(1):31-42. PubMed ID: 30614794
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
18. Correlation of CD44v6 expression with ovarian cancer progression and recurrence.
Shi J; Zhou Z; Di W; Li N
BMC Cancer; 2013 Apr; 13():182. PubMed ID: 23565736
[TBL] [Abstract][Full Text] [Related]
19. Wnt antagonist as therapeutic targets in ovarian cancer.
Y KN; Perumalsamy NK; Warrier S; Perumalsamy LR; Dharmarajan A
Int J Biochem Cell Biol; 2022 Apr; 145():106191. PubMed ID: 35272015
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
